Embargo will expire:
23-Sep-2024 5:00 PM EDT
Released to reporters: 23-Sep-2024 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
When an aggressive cancer launches an invasion on the human body, anything that can be done to slow down or better understand that fast-paced assault is going to be a bonus.
UWF alumni, community advocates Stephen and Mona Wright gift $500,000 to establish new institute
access_time Embargo lifts in 2 days
Embargo will expire:
23-Sep-2024 5:00 PM EDT
Released to reporters: 23-Sep-2024 10:00 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Ben Williamson to lead Sensiva Health as Dr. Jim Silliman is stepping down as CEO and will transition to The Board of Directors, effective immediately.
access_time Embargo lifts in 2 days
Embargo will expire:
26-Sep-2024 9:00 AM EDT
Released to reporters: 23-Sep-2024 9:00 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 26-Sep-2024 9:00 AM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Scientists from the American Cancer Society (ACS) are presenting research studies at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) Quality Care Symposium (QCS) September 27-28 in San Francisco, CA.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for ISPOR Europe 2024. The conference is the leading European conference for health economics and outcomes research (HEOR) and is scheduled for 17-20 November in Barcelona, Spain with the theme, “Generating Evidence Toward Health and Well-Being.”
People with alcohol use disorder (AUD) who are at risk of advanced liver disease are less likely to be referred for liver evaluation and care if they present primarily with alcohol-related mental health issues or a mental health diagnosis, according to a study of referral practices in Virginia’s largest health system. The findings point to the possibility of widespread missed opportunities for treating three conditions that commonly co-occur: AUD, mental health disorders, and liver disease. Recent years have seen notable increases in the USA in alcohol-related deaths, mental health disorders, and hospital admissions relating to alcohol use and concurrent mental health conditions. AUD is a significant cause of liver disease, and both addiction and co-occurring mental illness can be barriers to successful liver treatment. Integrating AUD treatment, mental health care, and hepatology (liver care) is necessary to improve outcomes, but data suggests this approach is not the norm. For the st
The Global Ultrasound Institute (GUSI) is proud to announce the launch of the GUSI Fellowships Platform, an innovative online platform designed to empower learners around the world to achieve confidence and competency in point-of-care ultrasound (POCUS).
A mother and daughter survive complex brain aneurysms, including the daughter's ruptured aneurysm, after receiving care from neurosurgeon Rafael De Oliveira Sillero, M.D., and his partners at UT Southwestern Medical Center.
Today, the FDA announced the first approved treatment for Niemann-Pick Type C (NPC) disease: an oral medication named Miplyffa (arimoclomol). Sean Kassen, director of the Ara Parseghian Medical Research Fund at the University of Notre Dame, said this represents the beginning of a new and hopeful era for NPC families.
Dr. Jeremie Calais received two grants from Novartis totaling $4 million aimed at improving the effectiveness of the radiation-emitting targeted therapy 177-Lu-PSMA-617 for patients with metastatic castration-resistant prostate cancer (mCRPC), one of the most challenging forms of the disease.
An eight-year project aims to uncover the complex web of interacting factors that drive oral health inequity, which in turn affects many other serious health conditions.
Open Disparities Narrowing Among Patients Undergoing Blood Stem Cell Transplant, Roswell Park Study Reveals configuration options Historically, some patients with blood cancers have been less likely than others to receive stem cell transplant, also known as bone marrow transplant.
Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, which is part of the body's "smart system" that monitors for threats and fights them with customized defenses.
Hunter doesn’t remember much from his time at Children’s Hospital Los Angeles, but more than a decade later, one small moment has stuck with him in multiple ways.A blonde woman asks him: “She’d hold up an array of ChapSticks,” Hunter explains, “blueberry, strawberry, green apple, root beer float and chocolate.”
The American Dental Hygienists’ Association (ADHA®) and Colgate Oral Pharmaceuticals, Inc, a Colgate-Palmolive Company, are proud to partner together for a fourth year in a row in support of October’s National Dental Hygiene Month (NDHM).
access_time Embargo lifts in 2 days
Embargo will expire:
25-Sep-2024 4:00 PM EDT
Released to reporters: 19-Sep-2024 3:05 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 25-Sep-2024 4:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.